Stock Scorecard
Stock Summary for Alpha Teknova Inc (TKNO) - $5.42 as of 6/5/2026 8:00:34 PM EST
Total Score
7 out of 30
Safety Score
8 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for TKNO
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for TKNO
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for TKNO
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for TKNO
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for TKNO (8 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 0 |
| Book Value (Max of 10) | 2 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 4 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 4 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for TKNO
Financial Details for TKNO
Company Overview |
|
|---|---|
| Ticker | TKNO |
| Company Name | Alpha Teknova Inc |
| Country | N/A |
| Description | Alpha Teknova Inc (TKNO) is a leading entity in the synthetic biology sector, specializing in the production of vital biological reagents and supplements that cater to life sciences research and biomanufacturing. The company's offerings play a pivotal role in high-demand areas such as vaccine development, cell and gene therapy, and diagnostic testing, underscored by a commitment to quality and exceptional customer service. With a robust biotechnology foundation and a strong focus on innovation, Alpha Teknova is well-equipped to capitalize on growth opportunities in the rapidly evolving life sciences market, positioning itself as a valuable investment for institutional stakeholders. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 5.42 |
| Price 4 Years Ago | 5.64 |
| Last Day Price Updated | 6/5/2026 8:00:34 PM EST |
| Last Day Volume | 232,362 |
| Average Daily Volume | 134,796 |
| 52-Week High | 6.68 |
| 52-Week Low | 1.91 |
| Last Price to 52 Week Low | 183.77% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 47.68 |
| Sector PE | 65.46 |
| 5-Year Average PE | -13.76 |
| Free Cash Flow Ratio | 67.75 |
| Industry Free Cash Flow Ratio | 12.67 |
| Sector Free Cash Flow Ratio | 33.13 |
| Current Ratio Most Recent Quarter | 4.59 |
| Total Cash Per Share | 0.08 |
| Book Value Per Share Most Recent Quarter | 1.28 |
| Price to Book Ratio | 4.46 |
| Industry Price to Book Ratio | 19.49 |
| Sector Price to Book Ratio | 7.38 |
| Price to Sales Ratio Twelve Trailing Months | 6.93 |
| Industry Price to Sales Ratio Twelve Trailing Months | 3.27 |
| Sector Price to Sales Ratio Twelve Trailing Months | 4.69 |
| Analyst Buy Ratings | 4 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 53,614,000 |
| Market Capitalization | 290,587,880 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 35.47% |
| Reported EPS 12 Trailing Months | -0.31 |
| Reported EPS Past Year | -0.08 |
| Reported EPS Prior Year | -0.33 |
| Net Income Twelve Trailing Months | -17,169,000 |
| Net Income Past Year | -17,259,000 |
| Net Income Prior Year | -26,745,000 |
| Quarterly Revenue Growth YOY | 13.10% |
| 5-Year Revenue Growth | 5.30% |
| Operating Margin Twelve Trailing Months | -38.80% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 4,306,000 |
| Total Cash Past Year | 5,912,000 |
| Total Cash Prior Year | 3,708,000 |
| Net Cash Position Most Recent Quarter | -8,864,000 |
| Net Cash Position Past Year | -7,211,000 |
| Long Term Debt Past Year | 13,123,000 |
| Long Term Debt Prior Year | 9,443,000 |
| Total Debt Most Recent Quarter | 13,170,000 |
| Equity to Debt Ratio Past Year | 0.84 |
| Equity to Debt Ratio Most Recent Quarter | 0.83 |
| Total Stockholder Equity Past Year | 68,775,000 |
| Total Stockholder Equity Prior Year | 82,394,000 |
| Total Stockholder Equity Most Recent Quarter | 64,924,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -8,865,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.17 |
| Free Cash Flow Past Year | -9,794,000 |
| Free Cash Flow Prior Year | -13,516,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.46 |
| MACD Signal | 0.34 |
| 20-Day Bollinger Lower Band | 1.27 |
| 20-Day Bollinger Middle Band | 3.13 |
| 20-Day Bollinger Upper Band | 4.99 |
| Beta | 0.47 |
| RSI | 72.61 |
| 50-Day SMA | 4.07 |
| 150-Day SMA | 4.22 |
| 200-Day SMA | 4.19 |
System |
|
| Modified | 6/4/2026 9:49:21 AM EST |